铁状态与2型糖尿病因果关系的遗传学支持:孟德尔随机化研究
本研究采用两样本孟德尔随机化方法,利用4种全身铁状态生物标志物的遗传工具变量,评估遗传预测的铁状态对2型糖尿病风险的影响。分析基于铁状态遗传学联盟的48 972名个体和糖尿病遗传学复制与Meta分析联盟的74 124例病例及824 006例对照。结果显示遗传预测的血清铁、铁蛋白和转铁蛋白饱和度与2型糖尿病风险正相关,而转铁蛋白与风险负相关,支持全身铁状态升高与2型糖尿病风险增加存在因果关联。
要点
- 遗传预测的血清铁、铁蛋白和转铁蛋白饱和度升高与2型糖尿病风险增加相关。
- 遗传预测的转铁蛋白升高(反映铁状态降低)与2型糖尿病风险降低相关。
- 遗传证据支持全身铁状态升高与2型糖尿病风险增加存在因果关联。
核心结论
- 遗传证据支持全身铁状态升高与2型糖尿病风险增加存在因果关联。
研究设计与样本
- 采用两样本孟德尔随机化分析评估遗传预测的全身铁状态对2型糖尿病风险的因果效应。
- 从铁状态遗传学联盟纳入48 972名个体中选取与4种铁状态生物标志物强关联(P < 5 × 10-8)的遗传变异。
- 将上述遗传工具变量应用于糖尿病遗传学复制与Meta分析联盟的2型糖尿病病例对照研究(74 124例病例和824 006例对照)。
- 敏感性分析采用简单中位数、加权中位数、MR-Egger、混合模型MR分析、加权等位基因评分和基于贝叶斯模型平均的MR方法。
主要发现
- 遗传工具变量预测的血清铁与2型糖尿病风险正相关(OR:1.07;95% CI,1.02-1.12)。
- 遗传工具变量预测的铁蛋白与2型糖尿病风险正相关(OR:1.19;95% CI,1.08-1.32)。
- 遗传工具变量预测的转铁蛋白饱和度与2型糖尿病风险正相关(OR:1.06;95% CI,1.02-1.09)。
- 遗传工具变量预测的转铁蛋白(反映铁状态降低的标志物)与2型糖尿病风险负相关(OR:0.91;95% CI,0.87-0.96)。
局限性
- 需要基于个体水平数据在不同种族背景中进一步研究,并探讨潜在机制以降低2型糖尿病风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Iron overload is a known risk factor for type 2 diabetes (T2D); however, iron overload and iron deficiency have both been associated with metabolic disorders in observational studies. OBJECTIVE: Using mendelian randomization (MR), we assessed how genetically predicted systemic iron status affected T2D risk. METHODS: A 2-sample MR analysis was used to obtain a causal estimate. We selected genetic variants strongly associated (P < 5 × 10-8) with 4 biomarkers of systemic iron status from a study involving 48 972 individuals performed by the Genetics of Iron Status consortium and applied these biomarkers to the T2D case-control study (74 124 cases and 824 006 controls) performed by the Diabetes Genetics Replication and Meta-analysis consortium. The simple median, weighted median, MR-Egger, MR analysis using mixture-model, weighted allele scores, and MR based on a Bayesian model averaging approaches were used for the sensitivity analysis. RESULTS: Genetically instrumented serum iron (odds ratio [OR]: 1.07; 95% CI, 1.02-1.12), ferritin (OR: 1.19; 95% CI, 1.08-1.32), and transferrin saturation (OR: 1.06; 95% CI, 1.02-1.09) were positively associated with T2D. In contrast, genetically instrumented transferrin, a marker of reduced iron status, was inversely associated with T2D (OR: 0.91; 95% CI, 0.87-0.96). CONCLUSION: Genetic evidence supports a causal link between increased systemic iron status and increased T2D risk. Further studies involving various ethnic backgrounds based on individual-level data and studies regarding the underlying mechanism are warranted for reducing the risk of T2D.
引用
- Wang X, Fang X, Zheng W, et al. Genetic Support of A Causal Relationship Between Iron Status and Type 2 Diabetes: A Mendelian Randomization Study. J Clin Endocrinol Metab. 2021. PMID: 34147035. doi:10.1210/clinem/dgab454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。